Davide Marangon

MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis

Davide Lecca, Davide Marangon, G. Coppolino et al. · Scientific Reports · 2016 · 72 citations · Full text

Differential local tissue permissiveness influences the final fate of <scp>GPR</scp>17‐expressing oligodendrocyte precursors in two distinct models of demyelination

G. Coppolino, Davide Marangon, Camilla Negri et al. · Glia · 2018 · 51 citations · Full text

In vivo silencing of miR‐125a‐3p promotes myelin repair in models of white matter demyelination

Davide Marangon, Enrica Boda, Roberta Parolisi et al. · Glia · 2020 · 41 citations · Full text

Immunology, Vivo Silencing, Mir‐125a‐3p Promotes +18

Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis

Chiara Parravicini, Davide Lecca, Davide Marangon et al. · PLoS ONE · 2020 · 24 citations · Full text

Drug Target, Immunology, Vivo Gpr17 Ligand +18

The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients

Jacopo Angelini, Davide Marangon, Stefano Raffaele et al. · International Journal of Molecular Sciences · 2021 · 22 citations · Full text

Neurological Disorder, White Matter, Immunology +20